Nasdaq Initiates Delisting Proceedings for Dyadic International
DYAI sits 32% above its 52-week low of $0.655.
Summary
Dyadic International has received a formal notice from Nasdaq initiating delisting proceedings. This action stems from the company's failure to meet both the $1.00 minimum bid price rule and other continued listing standards. This follows multiple prior deficiency notices from Nasdaq, as detailed in SEC filings from March and May, and the company's recent attempt to gain shareholder approval for a reverse stock split to avoid this outcome. The company plans to request a hearing, which will temporarily stay the delisting, with a potential compliance extension through December 15, 2026. Delisting would severely impact the company's liquidity and investor confidence.
At the time of this announcement, DYAI was trading at $0.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $31.5M. The 52-week trading range was $0.65 to $1.35. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.